These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1301644)

  • 21. Rilmenidine selectivity for imidazoline receptors in human brain.
    Bricca G; Dontenwill M; Molines A; Feldman J; Tibirica E; Belcourt A; Bousquet P
    Eur J Pharmacol; 1989 Apr; 163(2-3):373-7. PubMed ID: 2566507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin.
    Ruiz-Ortega JA; Ugedo L; Pineda J; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):121-6. PubMed ID: 7477433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imidazoline receptors. Historic review and current status of knowledge].
    Moura D
    Acta Med Port; 1993 Dec; 6(12):599-604. PubMed ID: 8165931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
    Nikolic K; Agbaba D
    Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central cardiovascular effects of a noncatecholamine endogenous ligand for clonidine receptors.
    Bousquet P; Feldman J; Atlas D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S167-71. PubMed ID: 2455173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem.
    Bricca G; Dontenwill M; Molines A; Feldman J; Belcourt A; Bousquet P
    Eur J Pharmacol; 1989 Mar; 162(1):1-9. PubMed ID: 2721559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential patterns of local cerebral glucose utilisation associated with rilmenidine- or B-HT 933-induced hypotension.
    Browne SE; Macrae IM
    Brain Res; 1994 Dec; 666(2):216-22. PubMed ID: 7882031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imidazoline receptors.
    Bousquet P
    Neurochem Int; 1997 Jan; 30(1):3-7. PubMed ID: 9116584
    [No Abstract]   [Full Text] [Related]  

  • 31. (3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition.
    Struyker Boudier H; Teppema L; Cools A; Van Rossum J
    J Pharm Pharmacol; 1975 Nov; 27(11):882-3. PubMed ID: 1506
    [No Abstract]   [Full Text] [Related]  

  • 32. Production and characterization of an iminoimidazolidine specific monoclonal antibody using para-aminoclonidine as antigen.
    Dontenwill M; Molines A; Bricca G; Stutzman J; Kempf J; Belcourt A; Bousquet P
    Life Sci; 1992; 50(24):1859-68. PubMed ID: 1598072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines.
    Dontenwill M; Bricca G; Molines A; Bousquet P; Belcourt A
    Eur J Pharmacol; 1988 May; 149(3):249-55. PubMed ID: 3409953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.
    Tibiriça E; Feldman J; Mermet C; Monassier L; Gonon F; Bousquet P
    Eur J Pharmacol; 1991 Dec; 209(3):213-21. PubMed ID: 1686768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan.
    Tibiriça E; Feldman J; Mermet C; Gonon F; Bousquet P
    J Pharmacol Exp Ther; 1991 Feb; 256(2):606-13. PubMed ID: 1671597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors".
    Bousquet P; Feldman J; Tibirica E; Bricca G; Molines A; Dontenwill M; Belcourt A
    Am J Med; 1989 Sep; 87(3C):10S-13S. PubMed ID: 2571290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacology of imidazoline receptors and cardiovascular regulation. Imidazoline receptors and blood pressure].
    Bousquet P; Bricca G; Dontenwill M; Feldman J; Belcourt A; Tibiriça E
    Therapie; 1992 Nov; 47(6):525-30. PubMed ID: 1301644
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.